NP Bioinnovation A/S: Financial statements 2025
CVR: 41598263
Source: annual report 2025, Danish Business Authority
01/04/2024 – 31/03/2025
NP Bioinnovation A/S (CVR 41598263) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -32,360 and a net result of DKK -60,069 compared with DKK -80,271 the year before. Equity in the 2025 report amounted to DKK 167,890. The solvency ratio was 84.1%.
- Gross Profit
- DKK -32,360
- Profit/Loss
- DKK -60,069
- Equity
- DKK 167,890
- Total Assets
- DKK 199,732
- Employees
- 0
Official annual report
How creditworthy is NP Bioinnovation A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of September 24, 2025, Allan Traugott Wehnert has joined the board of directors of NP Bioinnovation A/S.
As of September 24, 2025, Henrik Keller has left the board of directors of NP Bioinnovation A/S.
On March 10, 2025, the company changed its name from NP Communications A/S to NP Bioinnovation A/S.
As of January 10, 2025, Peter Severin Bach has joined the board of directors of NP Bioinnovation A/S.
As of January 10, 2025, Christian Torben Hill-Madsen has left the board of directors of NP Bioinnovation A/S.
On January 10, 2025, the company changed its name from Managementselskabet af 12.08.2020 A/S to NP Communications A/S.
About NP Bioinnovation A/S
NP Bioinnovation A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named NP Communications A/S and Managementselskabet af 12.08.2020 A/S. The management consists of Christian Torben Hill-Madsen. The board consists of Peter Severin Bach (chair), Allan Traugott Wehnert and Henrik Rouf. The company is owned by Nordicus Partners Corporation. The company has 12 employees (2026). In 2026, the company reported a gross profit of DKK 4,853,562 and a net result of DKK -5,521,565 compared with DKK -60,069 the year before. Equity in the 2026 report amounted to DKK -5,353,675.